Loeillot Olivier
Reporting owner on Forms 3, 4 and 5, CIK 1995525.
Loeillot Olivier reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-10-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RGEN · REPLIGEN CORPCIK 730272 | director, officer (Chief Executive Officer) | 3 | 2026-10-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RGEN · REPLIGEN CORPCommon Stock | 2026-10-05 | S sold | -1,333 | $178.75 | 45,788 | Form 4 |
| RGEN · REPLIGEN CORPCommon Stock | 2026-10-05 | M exercised | +4,202 | $154.96 | 49,990 | Form 4 |
| RGEN · REPLIGEN CORPCommon Stock | 2026-10-05 | S sold | -4,202 | $190 | 45,788 | Form 4 |
| RGEN · REPLIGEN CORPStock Option (Right to Buy), derivative | 2026-10-05 | M exercised | -4,202 | $0 | 8,405 | Form 4 |
| REPLIGEN CORP Common Stock | 2026-10-02 | F withheld for tax | -1,248 | $181.7 | 47,121 | Form 4 |
| REPLIGEN CORP Common Stock | 2026-09-24 | M exercised | +8,404 | $154.96 | 56,773 | Form 4 |
| REPLIGEN CORP Common Stock | 2026-09-24 | S sold | -8,404 | $190 | 48,369 | Form 4 |
| REPLIGEN CORP Common Stock | 2026-09-24 | M exercised | +4,542 | $155.38 | 52,911 | Form 4 |
| REPLIGEN CORP Common Stock | 2026-09-24 | S sold | -4,542 | $190 | 48,369 | Form 4 |
| REPLIGEN CORP Stock Option (Right to Buy), derivative | 2026-09-24 | M exercised | -8,404 | $0 | 12,607 | Form 4 |
| REPLIGEN CORP Stock Option (Right to Buy), derivative | 2026-09-24 | M exercised | -4,542 | $0 | 9,085 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-065238 | REPLIGEN CORP | 2026-10-06 | ||
| Form 4 0001628280-26-064889 | REPLIGEN CORP | 2026-10-05 | ||
| Form 4 0001628280-26-063572 | REPLIGEN CORP | 2026-09-25 |